Mesoblast
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $34,454 | $34,454 | $25,671 | $25,671 |
Gross Profit | 49,323 | 49,323 | -1,212 | -1,212 |
EBITDA | -9,327 | -9,327 | -12,533 | -12,533 |
EBIT | -11,465 | -11,465 | -14,159 | -14,159 |
Net Income | -8,669 | -8,669 | -20,081 | -20,081 |
Net Change In Cash | 34,454 | 34,454 | 25,671 | 25,671 |
Free Cash Flow | -6,948 | -4,463 | -15,691 | -15,255 |
Cash | 102,914 | 102,914 | 129,575 | 129,975 |
Basic Shares | 129,768 | 129,768 | 129,204 | 129,204 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $120,787 | $17,198 | $5,902 | $7,501 |
Gross Profit | 101,575 | 12,068 | -35,168 | -47,421 |
EBITDA | -42,877 | -73,659 | -53,306 | -58,550 |
EBIT | -51,501 | -80,059 | -57,972 | -62,657 |
Net Income | -57,756 | -102,142 | -87,956 | -81,889 |
Net Change In Cash | 120,787 | 17,198 | 5,902 | 7,501 |
Free Cash Flow | -44,728 | -50,684 | -48,789 | -63,583 |
Cash | 47,390 | 161,158 | 62,563 | 70,920 |
Basic Shares | 129,486 | 120,779 | 98,670 | 83,926 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$0.07 |
2025-06-30 | -$0.04 |
2025-03-31 | $0 |